Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 111

1.

Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance.

Ricciardelli C, Lokman NA, Pyragius CE, Ween MP, Macpherson AM, Ruszkiewicz A, Hoffmann P, Oehler MK.

Oncotarget. 2017 Jan 27. doi: 10.18632/oncotarget.14867. [Epub ahead of print]

2.

Cervical Pap smear screening is coming to an end.

Oehler MK.

Maturitas. 2016 Dec;94:11-12. doi: 10.1016/j.maturitas.2016.08.009. No abstract available.

PMID:
27823728
3.

Novel IEF Peptide Fractionation Method Reveals a Detailed Profile of N-Terminal Acetylation in Chemotherapy-Responsive and -Resistant Ovarian Cancer Cells.

Weiland F, Arentz G, Klingler-Hoffmann M, McCarthy P, Lokman NA, Kaur G, Oehler MK, Hoffmann P.

J Proteome Res. 2016 Nov 4;15(11):4073-4081.

PMID:
27569743
4.

Annexin A2 and alpha actinin 4 expression correlates with metastatic potential of primary endometrial cancer.

Mittal P, Klingler-Hoffmann M, Arentz G, Winderbaum L, Kaur G, Anderson L, Scurry J, Leung Y, Stewart CJ, Carter J, Hoffmann P, Oehler MK.

Biochim Biophys Acta. 2016 Oct 23. pii: S1570-9639(16)30221-7. doi: 10.1016/j.bbapap.2016.10.010. [Epub ahead of print]

PMID:
27784647
5.

WOMEN IN CANCER THEMATIC REVIEW: Ovarian cancer-peritoneal cell interactions promote extracellular matrix processing.

Ricciardelli C, Lokman NA, Ween MP, Oehler MK.

Endocr Relat Cancer. 2016 Nov;23(11):T155-T168. Review.

6.

Prognostic Factors of Recurrence and Survival in Vulvar Melanoma: Subgroup Analysis of the VULvar CANcer Study.

Iacoponi S, Rubio P, Garcia E, Oehler MK, Diez J, Diaz-De la Noval B, Mora P, Gardella B, Gomez I, Kotsopoulos IC, Zalewski K, Zapardiel I; VULCAN Study collaborative group..

Int J Gynecol Cancer. 2016 Sep;26(7):1307-12. doi: 10.1097/IGC.0000000000000768.

PMID:
27465889
7.

N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.

Everest-Dass AV, Briggs MT, Kaur G, Oehler MK, Hoffmann P, Packer NH.

Mol Cell Proteomics. 2016 Sep;15(9):3003-16. doi: 10.1074/mcp.M116.059816.

PMID:
27412689
8.

MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia.

Zhang C, Arentz G, Winderbaum L, Lokman NA, Klingler-Hoffmann M, Mittal P, Carter C, Oehler MK, Hoffmann P.

Int J Mol Sci. 2016 Jul 8;17(7). pii: E1088. doi: 10.3390/ijms17071088.

9.

Lymph node metastasis of primary endometrial cancers: Associated proteins revealed by MALDI imaging.

Mittal P, Klingler-Hoffmann M, Arentz G, Winderbaum L, Lokman NA, Zhang C, Anderson L, Scurry J, Leung Y, Stewart CJ, Carter J, Kaur G, Oehler MK, Hoffmann P.

Proteomics. 2016 Jun;16(11-12):1793-801. doi: 10.1002/pmic.201500455.

PMID:
27061135
10.

Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.

Lokman NA, Pyragius CE, Ruszkiewicz A, Oehler MK, Ricciardelli C.

Transl Res. 2016 May;171:83-95.e1-2. doi: 10.1016/j.trsl.2016.02.002.

PMID:
26925708
11.

PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations.

Pharoah PD, Song H, Dicks E, Intermaggio MP, Harrington P, Baynes C, Alsop K; Australian Ovarian Cancer Study Group., Bogdanova N, Cicek MS, Cunningham JM, Fridley BL, Gentry-Maharaj A, Hillemanns P, Lele S, Lester J, McGuire V, Moysich KB, Poblete S, Sieh W, Sucheston-Campbell L, Widschwendter M; Ovarian Cancer Association Consortium., Whittemore AS, Dörk T, Menon U, Odunsi K, Goode EL, Karlan BY, Bowtell DD, Gayther SA, Ramus SJ.

J Natl Cancer Inst. 2016 Jan 27;108(3). pii: djv347. doi: 10.1093/jnci/djv347.

PMID:
26823519
12.

High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq.

Kondrashova O, Love CJ, Lunke S, Hsu AL; Australian Ovarian Cancer Study (AOCS) Group., Waring PM, Taylor GR.

PLoS One. 2015 Nov 16;10(11):e0143006. doi: 10.1371/journal.pone.0143006.

13.

Proteomics of endometrial cancer diagnosis, treatment, and prognosis.

Mittal P, Klingler-Hoffmann M, Arentz G, Zhang C, Kaur G, Oehler MK, Hoffmann P.

Proteomics Clin Appl. 2016 Mar;10(3):217-29. doi: 10.1002/prca.201500055. Review.

PMID:
26541900
14.

The role of ABC transporters in ovarian cancer progression and chemoresistance.

Ween MP, Armstrong MA, Oehler MK, Ricciardelli C.

Crit Rev Oncol Hematol. 2015 Nov;96(2):220-56. doi: 10.1016/j.critrevonc.2015.05.012. Review.

PMID:
26100653
15.

Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer - a population-based study.

Anuradha S, Donovan PJ, Webb PM, Brand AH, Goh J, Friedlander M, Oehler MK, Quinn M, Steer C, Jordan SJ.

Acta Oncol. 2016;55(2):226-33. doi: 10.3109/0284186X.2015.1054950.

PMID:
26079434
16.

Macrosomic and low birth weight neonates in Pacific Islanders from Samoa: a case-control study.

Tsitas M, Schmid BC, Oehler MK, Tempfer CB.

Arch Gynecol Obstet. 2015 Dec;292(6):1261-6. doi: 10.1007/s00404-015-3773-3.

PMID:
26044149
17.

Whole-genome characterization of chemoresistant ovarian cancer.

Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, Kassahn KS, Newell F, Quinn MC, Kazakoff S, Quek K, Wilhelm-Benartzi C, Curry E, Leong HS; Australian Ovarian Cancer Study Group., Hamilton A, Mileshkin L, Au-Yeung G, Kennedy C, Hung J, Chiew YE, Harnett P, Friedlander M, Quinn M, Pyman J, Cordner S, O'Brien P, Leditschke J, Young G, Strachan K, Waring P, Azar W, Mitchell C, Traficante N, Hendley J, Thorne H, Shackleton M, Miller DK, Arnau GM, Tothill RW, Holloway TP, Semple T, Harliwong I, Nourse C, Nourbakhsh E, Manning S, Idrisoglu S, Bruxner TJ, Christ AN, Poudel B, Holmes O, Anderson M, Leonard C, Lonie A, Hall N, Wood S, Taylor DF, Xu Q, Fink JL, Waddell N, Drapkin R, Stronach E, Gabra H, Brown R, Jewell A, Nagaraj SH, Markham E, Wilson PJ, Ellul J, McNally O, Doyle MA, Vedururu R, Stewart C, Lengyel E, Pearson JV, Waddell N, deFazio A, Grimmond SM, Bowtell DD.

Nature. 2015 May 28;521(7553):489-94. doi: 10.1038/nature14410. Erratum in: Nature. 2015 Nov 19;527(7578):398.

PMID:
26017449
18.

Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.

Ricciardelli C, Lokman NA, Cheruvu S, Tan IA, Ween MP, Pyragius CE, Ruszkiewicz A, Hoffmann P, Oehler MK.

Clin Exp Metastasis. 2015 Jun;32(5):441-55. doi: 10.1007/s10585-015-9718-1.

PMID:
25895698
19.

Robotics versus conventional laparoscopy for endometrial cancer: Where are we now?

Oehler MK.

Maturitas. 2015 Jun;81(2):241-2. doi: 10.1016/j.maturitas.2015.03.019. No abstract available.

PMID:
25890588
20.

Improvements in progression-free and overall survival due to the use of anti-angiogenic agents in gynecologic cancers.

Schmid BC, Oehler MK.

Curr Treat Options Oncol. 2015 Jan;16(1):318. doi: 10.1007/s11864-014-0318-0. Review.

PMID:
25750175
Items per page

Supplemental Content

Loading ...
Support Center